## CDW: CDW Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -5.3% below STRENGTH zone (3.0-6.0%); PEG 1.53 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($130.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. CDW Signs Senior Unsecured Credit Facility With JPMorgan Chase and Lenders**
- Source: TradingView â€” Track All Markets | 20251223T133448 | Bullish | Relevance: 100%
- CDW has entered into a new five-year, $2.8845 billion senior unsecured credit facility with JPMorgan Chase and a syndicate of lenders. This facility, comprising a term loan and a multi-currency revolver, replaces and refinances previous agreements from December 2021. The new structure aims to enhance liquidity, streamline capital structure, and adapt to current market conditions.

**2. CDW Price Target Reduced as Morgan Stanley Analyst Turns More Selective on IT Hardware Exposure**
- Source: Finviz | 20251222T220815 | Neutral | Relevance: 100%
- Morgan Stanley reduced its price target on CDW Corporation (NASDAQ:CDW) to $177 from $191, maintaining an Overweight rating. This decision stems from a more selective outlook on IT hardware exposure, favoring companies tied to cloud spending and product refresh cycles while steering clear of memory-linked stocks. Despite the reduced price target, CDW's Q3 results showed strong performance, with net sales up 4% and gross profit up 5%, demonstrating resilience in a mixed IT spending environment.

**3. CDW Price Target Reduced as Morgan Stanley Analyst Turns More Selective on IT Hardware Exposure**
- Source: Insider Monkey | 20251222T160838 | Neutral | Relevance: 100%
- Morgan Stanley reduced its price target on CDW Corporation to $177 from $191, maintaining an Overweight rating. The firm is becoming more selective in IT hardware, favoring companies linked to cloud spending and product refresh cycles while steering away from stocks with heavy memory exposure. CDW's Q3 results showed strong performance in government, education, and small business segments, with management reaffirming a positive 2025 outlook for the US IT market.

**4. CDW December 2026 Options Begin Trading**
- Source: Nasdaq | 20251223T160746 | Somewhat-Bullish | Relevance: 100%
- New options contracts for CDW Corp (CDW) with a December 2026 expiration have begun trading, offering opportunities for investors due to their longer time value. BNK Invest's YieldBoost formula highlights specific put and call contracts, providing insights into potential returns for selling options or implementing covered call strategies. The article analyzes the potential profitability and risks associated with these new options, considering implied volatility and historical stock performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $177 | $191 | -7% |
| 2025-11-25 | Raymond James | $185 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-11-25 | Raymond James | up | Strong Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 20 ($0.12M) |
| Sells | 4 ($1.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.2% (+8.2%)
- State Street Corpora: 4.5% (-0.4%)
- JPMORGAN CHASE & CO: 4.1% (+250.4%)
- Select Equity Group : 3.2% (+2.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-6.4% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 15.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.53 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 43%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($1.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.1B |
| Beta | 1.06 |
| 52W Range | $135.63 - $222.92 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.53 |
| Forward P/E | 13.1 |
| Current P/E | 14.0 |
| YoY Growth | 6.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.1% to -5.3% (-6.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.3pp (needs >3.0% for momentum thesis). Underperforming sector by 5.5pp, stock-specific weakness. Below SMA200 (0.85x), long-term trend not supportive. MACD histogram bearish (-0.56), momentum weakening. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.26% (CS: 5) | Weak |
| RSI_14 | 34.4 | Neutral |
| MACD Histogram | -0.56 | Bearish |
| vs SMA20 | 0.957x | Below |
| vs SMA50 | 0.939x | Below |
| vs SMA200 | 0.846x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.14
- **Stop Loss:** $130.40 (5.6% risk)
- **Target:** $145.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 155
- **Position Value:** $21,411.70
- **Portfolio %:** 21.41%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-11 (Est: $2.44)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.62 | $2.71 | +3.4% |
| 2025Q2 | $2.49 | $2.60 | +4.4% |
| 2025Q1 | $1.96 | $2.15 | +9.5% |
| 2024Q4 | $2.32 | $2.48 | +6.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*